Nastech Pharmaceutical Company News

Marina Biotech, Inc. , a leading nucleic acid-based drug discovery and development company, today announced that the Company's licensee, Mirna Therapeutics, has reported that they have initiated a Phase 1 clinical study of MRX34, the first miRNA to advance into a human clinical trial for cancer.

He brings 20 years of work experience including 13 years in the life science sector with a track record of fundraising and collaborative agreements.

Atossa Genetics has had a huge run up. It went from $6.93 on March 13, 2013 to $11.30 at the time of this writing.

America's biopharmaceutical companies, including three in Bothell, are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report released today by the Pharmaceutical Research and Manufacturers of America .

Breast cancer is diagnosed in over 200,000 women annually in the US, according to the CDC.